Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Sierra Clinical Trial Dosimetry Results Support Low Dose Anti-CD45 Iodine (131I) Apamistamab [Iomab-B] for Targeted Lymphodepletion Prior to Adoptive Cell Therapy

Rajneesh Nath, MD, Eileen M Geoghegan, Matthew L. Ulrickson, MD, Jennifer A Spross, MA, Renee H Lichtenstein, BA, Sandy Konerth, MS, Darrell R. Fisher, PhD, Qing Liang, PhD, Dale Ludwig, PhD BS, Vijay Reddy, MD PhD, Mark S. Berger, MD, Boglarka Gyurkocza, MD

Blood (2019) 134 (Supplement_1): 1958.

https://doi.org/10.1182/blood-2019-128838

Published: 2019

Journal Articles

Safety and Efficacy of Yttrium-90-Labeled Anti-CD45 Antibody ( 90 Y-DOTA-BC8) Followed By a Standard Reduced-Intensity Hematopoietic Stem Cell Transplant (HCT) Regimen for Patients with Refractory/Relapsed Leukemia or High-Risk Myelodysplastic Syndrome (MDS)

Phuong T. Vo, MD, Ted Gooley, PhD, Joseph G. Rajendran, MD, Darrell R. Fisher, PhD, Johnnie J. Orozco, MD PhD, Damian J. Green, MD, Ajay K. Gopal, MD, Robyn Haaf, BS, Margaret E. Nartea, BS, Rainer F. Storb, MD, Frederick R. Appelbaum, MD, Oliver W. Press, MD PhD, John M. Pagel, MD PhD, Brenda M. Sandmaier, MD

Blood (2018) 132 (Supplement 1): 1018.

https://doi.org/10.1182/blood-2018-99-111915

Published: 2018

Journal Articles

A Phase II Trial of Myeloablative I-131-Tositumomab, Etoposide and Cyclophosphamide Followed by Autologous Transplantation for B-Cell Non-Hodgkin's Lymphoma

Ajay K. Gopal, MD, Ted A. Gooley, PhD, Joseph Rajendran, MD, John M. Pagel, MD, PhD, Darrell R. Fisher, PhD, David G. Maloney, MD, PhD, Frederick R. Appelbaum, MD, Andrew Shields, MD, Damian J. Green, MD, Oliver W. Press, MD, PhD

Blood (2012) 120 (21): 811.

https://doi.org/10.1182/blood.V120.21.811.811

Published: 2012

Journal Articles

High-Dose Myeloablative Zevalin Radioimmunotherapy with Tandem Stem-Cell Autografting Has Promising Activity, Minimal Toxicity and Full Feasibility in an Outpatient Setting.

Liliana Devizzi, MD, Ettore Seregni, MD, Anna Guidetti, MD, Chiara Forni, MD, Angela Coliva, MD, Michele Magni, MD, Massimo Di Nicola, MD, Carmelo Carlo-Stella, MD, Paola Matteucci, MD, Antonella De Pascale, MD, Claudia Erminero, MD, Marco Maccauro, MD, Carlo Chiesa, PhD, Emilio Bombardieri, MD, Pinuccia Valagussa, Alessandro M. Gianni, MD

Blood (2006) 108 (11): 3047.

https://doi.org/10.1182/blood.V108.11.3047.3047

Published: 2006

Journal Articles

131 I-Anti-CD45 Antibody Plus Busulfan/Cyclophosphamide in Matched Related Transplants for Acute Myeloid Leukemia in First Remission.

John M. Pagel, MD, PhD, Frederick R. Appelbaum, MD, Janet F. Eary, MD, Joseph G. Rajendran, MD, Darrell R. Fisher, PhD, Ted Gooley, PhD, Eneida Nemecek, MD, Katherine Ruffner, MD, Eileen Sickle, RN, Larry Durack, CNMT, Jeanette Carreras, MPH, Mary M. Horowitz, MD, MS, Ajay K. Gopal, MD, Oliver W. Press, MD, PhD, Paul J. Martin, MD, Irwin D. Bernstein, MD, Dana C. Matthews, MD

Blood (2004) 104 (11): 813.

https://doi.org/10.1182/blood.V104.11.813.813

Published: 2004

Journal Articles

A Myeloablative Regimen Incorporating Radiolabeled Anti-CD45 (BC8) Antibody Followed by Allogeneic Hematopoietic Cell Transplantation (HCT) for Patients with Advanced Acute Myeloid Leukemia (AML).

Eneida R. Nemecek, MD, John M. Pagel, MD, Joseph G. Rajendran, MD, Darrell R. Fisher, PhD, Frederick R. Appelbaum, MD, Oliver W. Press, MD, PhD, Dana C. Matthews, MD

Blood (2004) 104 (11): 828.

https://doi.org/10.1182/blood.V104.11.828.828

Published: 2004

Journal Articles

Targeting of a Heterologous Protein to a Regulated Secretion Pathway in Cultured Endothelial Cells

Yvonne H. Datta, Hagop Youssoufian, Peter W. Marks, Bruce M. Ewenstein

Blood (1999) 94 (8): 2696–2703.

https://doi.org/10.1182/blood.V94.8.2696.420k29_2696_2703

Published: 1999

Journal Articles

Phase I Study of 131 I-Anti-CD45 Antibody Plus Cyclophosphamide and Total Body Irradiation for Advanced Acute Leukemia and Myelodysplastic Syndrome

Dana C. Matthews, Frederick R. Appelbaum, Janet F. Eary, Darrell R. Fisher, Lawrence D. Durack, T. Edmond Hui, Paul J. Martin, David Mitchell, Oliver W. Press, Rainer Storb, Irwin D. Bernstein

Blood (1999) 94 (4): 1237–1247.

https://doi.org/10.1182/blood.V94.4.1237

Published: 1999

Journal Articles

Monocyte Arrest and Transmigration on Inflamed Endothelium in Shear Flow Is Inhibited by Adenovirus-Mediated Gene Transfer of IκB-

Kim S.C. Weber, Georg Draude, Wolfgang Erl, Rainer de Martin, Christian Weber

Blood (1999) 93 (11): 3685–3693.

https://doi.org/10.1182/blood.V93.11.3685

Published: 1999

Journal Articles

A20 Inhibits NF-κB Activation in Endothelial Cells Without Sensitizing to Tumor Necrosis Factor–Mediated Apoptosis

Christiane Ferran, Deborah M. Stroka, Anne Z. Badrichani, Jeffrey T. Cooper, Christopher J. Wrighton, Miguel Soares, Shane T. Grey, Fritz H. Bach

Blood (1998) 91 (7): 2249–2258.

https://doi.org/10.1182/blood.V91.7.2249

Published: 1998

NARROW

Sierra Clinical Trial Dosimetry Results Support Low Dose Anti-CD45 Iodine (131I) Apamistamab [Iomab-B] for Targeted Lymphodepletion Prior to Adoptive Cell Therapy

Safety and Efficacy of Yttrium-90-Labeled Anti-CD45 Antibody ( 90 Y-DOTA-BC8) Followed By a Standard Reduced-Intensity Hematopoietic Stem Cell Transplant (HCT) Regimen for Patients with Refractory/Relapsed Leukemia or High-Risk Myelodysplastic Syndrome (MDS)

A Phase II Trial of Myeloablative I-131-Tositumomab, Etoposide and Cyclophosphamide Followed by Autologous Transplantation for B-Cell Non-Hodgkin's Lymphoma

High-Dose Myeloablative Zevalin Radioimmunotherapy with Tandem Stem-Cell Autografting Has Promising Activity, Minimal Toxicity and Full Feasibility in an Outpatient Setting.

131 I-Anti-CD45 Antibody Plus Busulfan/Cyclophosphamide in Matched Related Transplants for Acute Myeloid Leukemia in First Remission.

A Myeloablative Regimen Incorporating Radiolabeled Anti-CD45 (BC8) Antibody Followed by Allogeneic Hematopoietic Cell Transplantation (HCT) for Patients with Advanced Acute Myeloid Leukemia (AML).

Targeting of a Heterologous Protein to a Regulated Secretion Pathway in Cultured Endothelial Cells

Phase I Study of 131 I-Anti-CD45 Antibody Plus Cyclophosphamide and Total Body Irradiation for Advanced Acute Leukemia and Myelodysplastic Syndrome

Monocyte Arrest and Transmigration on Inflamed Endothelium in Shear Flow Is Inhibited by Adenovirus-Mediated Gene Transfer of IκB-

A20 Inhibits NF-κB Activation in Endothelial Cells Without Sensitizing to Tumor Necrosis Factor–Mediated Apoptosis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only